Stability indicating eco-friendly quantitation of terbutaline and its pro-drug bambuterol using quantitative proton nuclear magnetic spectroscopy
- PMID: 38291471
- PMCID: PMC10829239
- DOI: 10.1186/s13065-024-01120-7
Stability indicating eco-friendly quantitation of terbutaline and its pro-drug bambuterol using quantitative proton nuclear magnetic spectroscopy
Abstract
Quantitative 1H-NMR became an increasingly important issue in pharmaceutical analytical chemistry. This study used NMR spectroscopy to assay the bronchodilator drug terbutaline sulfate and its pro-drug bambuterol hydrochloride in pure form and pharmaceutical preparations. The technique proceeded using deuterium oxide (D2O) as an 1H-NMR solvent and phloroglucinol anhydrous as an internal standard (IS). Comparatively, to the phloroglucinol signal at 5.9 ppm, the resulting quantitative signals of the studied drugs were corrected. The terbutaline singlet signal at 6.3 ppm was chosen for quantification, while the bambuterol quantitative singlet signal was at 2.9 ppm. The two drugs were rectilinear over the concentration range of 1.0-16.0 mg/mL. LOD values were 0.19 and 0.21 mg/mL while LOQ values were 0.58 and 0.64 mg/mL for terbutaline and bambuterol respectively. The developed method has been validated according to the International Conference of Harmonization (ICH) regarding linearity, accuracy, precision, specificity, and robustness. A greenness profile assessment was applied, and the method proved to be green. The method enables the assay of the two drugs in pure drug and pharmaceutical preparations. The method also enables the assay of the two drugs in the presence of each other; thus, it is considered a stability-indicating method where terbutaline is an acid degradation product of bambuterol.
Keywords: Bambuterol; NMR spectroscopy; Terbutaline.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline.R Soc Open Sci. 2018 Oct 31;5(10):181359. doi: 10.1098/rsos.181359. eCollection 2018 Oct. R Soc Open Sci. 2018. PMID: 30473864 Free PMC article.
-
Utility and greenness appraisal of nuclear magnetic resonance for sustainable simultaneous determination of three 1,4-benzodiazepines and their main impurity 2-amino-5-chlorobenzophenone.Sci Rep. 2023 Nov 30;13(1):21121. doi: 10.1038/s41598-023-48416-7. Sci Rep. 2023. PMID: 38036558 Free PMC article.
-
Greenness, blueness, and whiteness evaluation of a quantitative nuclear magnetic resonance procedure for concurrent assay of aspirin and omeprazole in their single and fixed-dose combined tablets.BMC Chem. 2025 May 5;19(1):117. doi: 10.1186/s13065-025-01477-3. BMC Chem. 2025. PMID: 40325414 Free PMC article.
-
Clinical pharmacokinetics of bambuterol.Clin Pharmacokinet. 1996 Oct;31(4):246-56. doi: 10.2165/00003088-199631040-00002. Clin Pharmacokinet. 1996. PMID: 8896942 Review.
-
Mechanism of action of bambuterol: a beta-agonist prodrug with sustained lung affinity.Agents Actions Suppl. 1991;34:71-8. Agents Actions Suppl. 1991. PMID: 1686529 Review.
Cited by
-
Comparison and Determination of the Content of Mosapride Citrate by Different qNMR Methods.Int J Mol Sci. 2024 Sep 27;25(19):10442. doi: 10.3390/ijms251910442. Int J Mol Sci. 2024. PMID: 39408772 Free PMC article.
References
-
- Svensson LA. Development of bambuterol; a long acting, orally active beta-agonist prodrug. Vienna: Springer; 1998.
-
- Commission BP, British Pharmacopoeia Her Majesty’s Stationary Office. 1998, London.
-
- Moreton RC. United States pharmacopeia-national formulary. J Excipients Food Chem. 2016;6(3):925.
LinkOut - more resources
Full Text Sources